Neogen Corporation Net Assets
Neogen Corporation net assets. Based on the latest financial reports, Neogen Corporation (NEOG) has net assets worth $2.09 Billion USD as of August 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.30 Billion) and total liabilities ($1.22 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore NEOG year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $2.09 Billion |
| % of Total Assets | 63.16% |
| Annual Growth Rate | N/A |
| 5-Year Change | 135.85% |
| 10-Year Change | 343.64% |
| Growth Volatility | 45.89 |
Net Assets of Neogen Corporation (1988–2026)
Net assets of Neogen Corporation from 1988 to 2026. This chart illustrates how Neogen Corporation's net assets have evolved over time, based on quarterly financial data. See NEOG equity financing ratio to measure how much of total assets are equity-financed.
Annual Net Assets for Neogen Corporation (1988–2026)
The table below shows the annual net assets of Neogen Corporation from 1988 to 2026. For live market cap and overall valuation, see Neogen Corporation market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2026-05-31 | $2.09 Billion | +1.05% |
| 2025-05-31 | $2.07 Billion | -34.12% |
| 2024-05-31 | $3.14 Billion | +0.32% |
| 2023-05-31 | $3.13 Billion | +253.20% |
| 2022-05-31 | $887.37 Million | +5.59% |
| 2021-05-31 | $840.38 Million | +15.89% |
| 2020-05-31 | $725.18 Million | +13.68% |
| 2019-05-31 | $637.90 Million | +13.87% |
| 2018-05-31 | $560.17 Million | +18.74% |
| 2017-05-31 | $471.76 Million | +16.73% |
| 2016-05-31 | $404.16 Million | +15.16% |
| 2015-05-31 | $350.96 Million | +14.58% |
| 2014-05-31 | $306.30 Million | +18.59% |
| 2013-05-31 | $258.29 Million | +17.91% |
| 2012-05-31 | $219.05 Million | +15.92% |
| 2011-05-31 | $188.98 Million | +23.47% |
| 2010-05-31 | $153.05 Million | +18.94% |
| 2009-05-31 | $128.68 Million | +15.67% |
| 2008-05-31 | $111.25 Million | +20.99% |
| 2007-05-31 | $91.94 Million | +42.44% |
| 2006-05-31 | $64.55 Million | +17.71% |
| 2005-05-31 | $54.84 Million | +14.62% |
| 2004-05-31 | $47.84 Million | +15.55% |
| 2003-05-31 | $41.40 Million | +16.47% |
| 2002-05-31 | $35.55 Million | +21.16% |
| 2001-05-31 | $29.34 Million | +13.69% |
| 2000-05-31 | $25.80 Million | +8.42% |
| 1999-05-31 | $23.80 Million | +0.85% |
| 1998-05-31 | $23.60 Million | +12.38% |
| 1997-05-31 | $21.00 Million | +135.96% |
| 1996-05-31 | $8.90 Million | +1.14% |
| 1995-05-31 | $8.80 Million | +14.29% |
| 1994-05-31 | $7.70 Million | +26.23% |
| 1993-05-31 | $6.10 Million | -4.69% |
| 1992-05-31 | $6.40 Million | -9.86% |
| 1991-05-31 | $7.10 Million | -10.13% |
| 1990-05-31 | $7.90 Million | +275.56% |
| 1989-05-31 | $-4.50 Million | -9.76% |
| 1988-05-31 | $-4.10 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Neogen Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 54010000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Neogen Corporation Net Assets Breakdown (May 2026)
Neogen Corporation net assets breakdown by equity component as of May 2026.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $34.80 Million | 1.66% |
| Other Comprehensive Income | $-13.60 Million | -0.65% |
| Other Components | $2.62 Billion | 124.99% |
| Total Equity | $2.09 Billion | 100.00% |
Neogen Corporation Competitors by Market Cap
The table below lists competitors of Neogen Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Zhejiang Huace Film TV Co
SHE:300133
|
$2.55 Billion |
|
Chenbro Micom Co Ltd
TW:8210
|
$2.55 Billion |
|
Joyoung Co Ltd
SHE:002242
|
$2.55 Billion |
|
Xiamen Kehua Hengsheng
SHE:002335
|
$2.56 Billion |
|
Mobimo Hldg
SW:MOBN
|
$2.55 Billion |
|
PHINIA Inc.
NYSE:PHIN
|
$2.55 Billion |
|
KWS SAAT SE & Co. KGaA
F:KWS
|
$2.55 Billion |
|
Benchmark Electronics Inc
NYSE:BHE
|
$2.55 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Neogen Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 2,071,254,000 to 2,092,900,000, a change of 21,646,000 (1.0%).
- Net loss of 7,900,000 reduced equity.
- Other comprehensive income increased equity by 15,298,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-7.90 Million | -0.38% |
| Other Comprehensive Income | $15.30 Million | +0.73% |
| Other Changes | $14.25 Million | +0.68% |
| Total Change | $- | 1.05% |
Book Value vs Market Value Analysis
This analysis compares Neogen Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.26x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1988-05-31 | $-0.20 | $12.10 | x |
| 1989-05-31 | $-0.18 | $12.10 | x |
| 1990-05-31 | $0.18 | $12.10 | x |
| 1991-05-31 | $0.16 | $12.10 | x |
| 1992-05-31 | $0.15 | $12.10 | x |
| 1993-05-31 | $0.14 | $12.10 | x |
| 1994-05-31 | $0.14 | $12.10 | x |
| 1995-05-31 | $0.17 | $12.10 | x |
| 1996-05-31 | $0.16 | $12.10 | x |
| 1997-05-31 | $0.33 | $12.10 | x |
| 1998-05-31 | $0.33 | $12.10 | x |
| 1999-05-31 | $0.34 | $12.10 | x |
| 2000-05-31 | $0.39 | $12.10 | x |
| 2001-05-31 | $0.44 | $12.10 | x |
| 2002-05-31 | $0.50 | $12.10 | x |
| 2003-05-31 | $0.48 | $12.10 | x |
| 2004-05-31 | $0.53 | $12.10 | x |
| 2005-05-31 | $0.60 | $12.10 | x |
| 2006-05-31 | $0.75 | $12.10 | x |
| 2007-05-31 | $1.08 | $12.10 | x |
| 2008-05-31 | $1.24 | $12.10 | x |
| 2009-05-31 | $1.42 | $12.10 | x |
| 2010-05-31 | $1.66 | $12.10 | x |
| 2011-05-31 | $1.98 | $12.10 | x |
| 2012-05-31 | $2.28 | $12.10 | x |
| 2013-05-31 | $2.65 | $12.10 | x |
| 2014-05-31 | $3.08 | $12.10 | x |
| 2015-05-31 | $3.51 | $12.10 | x |
| 2016-05-31 | $4.00 | $12.10 | x |
| 2017-05-31 | $4.61 | $12.10 | x |
| 2018-05-31 | $5.37 | $12.10 | x |
| 2019-05-31 | $6.08 | $12.10 | x |
| 2020-05-31 | $6.86 | $12.10 | x |
| 2021-05-31 | $7.85 | $12.10 | x |
| 2022-05-31 | $8.21 | $12.10 | x |
| 2023-05-31 | $16.59 | $12.10 | x |
| 2024-05-31 | $14.52 | $12.10 | x |
| 2025-05-31 | $9.55 | $12.10 | x |
| 2026-05-31 | $9.62 | $12.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Neogen Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.38%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.91%
- • Asset Turnover: 0.26x
- • Equity Multiplier: 1.60x
- Recent ROE (-0.38%) is below the historical average (4.87%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1988 | 0.00% | -22.92% | 0.92x | 0.00x | $-690.00K |
| 1989 | 0.00% | -8.06% | 1.35x | 0.00x | $-50.00K |
| 1990 | -2.53% | -3.33% | 0.64x | 1.19x | $-990.00K |
| 1991 | -11.27% | -13.33% | 0.71x | 1.20x | $-1.51 Million |
| 1992 | -12.50% | -12.12% | 0.87x | 1.19x | $-1.44 Million |
| 1993 | -8.20% | -6.58% | 1.04x | 1.20x | $-1.11 Million |
| 1994 | 11.69% | 8.41% | 1.18x | 1.18x | $130.00K |
| 1995 | 7.95% | 5.98% | 1.02x | 1.31x | $-180.00K |
| 1996 | -2.25% | -1.60% | 1.09x | 1.29x | $-1.09 Million |
| 1997 | 8.57% | 11.76% | 0.66x | 1.10x | $-300.00K |
| 1998 | 9.32% | 11.89% | 0.73x | 1.08x | $-160.00K |
| 1999 | 9.66% | 10.36% | 0.85x | 1.10x | $-80.00K |
| 2000 | 11.91% | 13.07% | 0.80x | 1.14x | $493.60K |
| 2001 | 10.81% | 9.08% | 1.06x | 1.13x | $236.30K |
| 2002 | 11.10% | 9.60% | 1.03x | 1.12x | $390.40K |
| 2003 | 11.56% | 10.30% | 0.97x | 1.16x | $646.80K |
| 2004 | 10.66% | 9.19% | 0.93x | 1.25x | $314.80K |
| 2005 | 10.79% | 9.43% | 0.98x | 1.17x | $432.50K |
| 2006 | 12.30% | 10.96% | 0.82x | 1.37x | $1.49 Million |
| 2007 | 9.92% | 10.59% | 0.82x | 1.15x | $-69.50K |
| 2008 | 10.87% | 11.81% | 0.81x | 1.14x | $973.20K |
| 2009 | 10.78% | 11.69% | 0.84x | 1.10x | $1.01 Million |
| 2010 | 11.45% | 12.47% | 0.78x | 1.18x | $2.22 Million |
| 2011 | 12.11% | 13.23% | 0.79x | 1.16x | $3.97 Million |
| 2012 | 10.28% | 12.23% | 0.73x | 1.15x | $607.60K |
| 2013 | 10.53% | 13.10% | 0.72x | 1.12x | $1.36 Million |
| 2014 | 9.19% | 11.38% | 0.72x | 1.13x | $-2.47 Million |
| 2015 | 9.55% | 11.84% | 0.72x | 1.12x | $-1.57 Million |
| 2016 | 9.05% | 11.38% | 0.71x | 1.12x | $-3.85 Million |
| 2017 | 9.28% | 12.11% | 0.68x | 1.12x | $-3.38 Million |
| 2018 | 11.27% | 15.70% | 0.65x | 1.10x | $7.13 Million |
| 2019 | 9.43% | 14.53% | 0.60x | 1.09x | $-3.61 Million |
| 2020 | 8.20% | 14.22% | 0.52x | 1.10x | $-13.04 Million |
| 2021 | 7.24% | 13.00% | 0.51x | 1.09x | $-23.16 Million |
| 2022 | 5.44% | 9.16% | 0.53x | 1.12x | $-40.43 Million |
| 2023 | -0.73% | -2.78% | 0.18x | 1.45x | $-336.29 Million |
| 2024 | -0.30% | -1.02% | 0.20x | 1.45x | $-323.84 Million |
| 2025 | -52.72% | -122.06% | 0.26x | 1.66x | $-1.30 Billion |
| 2026 | -0.38% | -0.91% | 0.26x | 1.60x | $-217.19 Million |
Industry Comparison
This section compares Neogen Corporation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $296,528,539
- Average return on equity (ROE) among peers: -35.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Neogen Corporation (NEOG) | $2.09 Billion | 0.00% | 0.58x | $2.55 Billion |
| Abbott Laboratories (ABT) | $2.83 Billion | 34.08% | 0.96x | $190.23 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-95.88 Million | 0.00% | 0.00x | $2.34 Million |
| Aethlon Medical Inc (AEMD) | $-3.66 Million | 0.00% | 0.00x | $1.11 Million |
| Acutus Medical Inc (AFIB) | $-11.59 Million | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $850.46 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $9.37 Million | 23.33% | 0.30x | $2.43 Million |
| Allurion Technologies, Inc. (ALUR) | $-77.98 Million | 0.00% | 0.00x | $21.01K |
| Autonomix Medical, Inc. Common Stock (AMIX) | $5.89 Million | -283.55% | 0.29x | $1.61 Million |
| Artivion Inc (AORT) | $276.20 Million | -4.84% | 1.86x | $1.03 Billion |
| Apyx Medical Inc (APYX) | $14.18 Million | 18.92% | 0.18x | $109.52 Million |
About Neogen Corporation
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage … Read more